TSXV:VM - Post Discussion
Post by
whitenorth72 on Dec 04, 2023 11:15am
The next step.
I'm assuming the next step to unlocking government grants and funding is as follows.
From their last PR.
Due to the sole source environment in Canada for barium contrast agents, clients have asked Voyageur to produce a full suite of products to allow them to make a seamless transition to Voyageur's product line. In response to client demand, Voyageur is currently working with Alberta Veterinarian Laboratories (AVL) and its subsidiary Solvet https://solvet.ca/, to accelerate the formulation and testing of the remaining products that the market requires to ensure supply chain security for our clients. AVL is currently formulating the next 3 products with Health Canada licences; MultiXBa, MultiXs and MultiXthin. Upon completion of our full suite of products, Voyageur will begin penetrating the Canadian radiology market.
Be the first to comment on this post